Actively Recruiting
GDF-15 and Early Outcomes After LVAD Implantation
Led by Akdeniz University · Updated on 2026-03-27
48
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.
CONDITIONS
Official Title
GDF-15 and Early Outcomes After LVAD Implantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and older
- Patients with advanced heart failure undergoing LVAD implantation
- Availability of preoperative GDF-15 measurement
- Ability to provide written informed consent or consent by a legally authorized representative according to local regulations
You will not qualify if you...
- Age under 18 years
- Active infection
- Active malignancy
- Severe hepatic failure
- Missing study data
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation
Antalya, Please Select:, Turkey (Türkiye), 07050
Actively Recruiting
Research Team
E
emel gündüz, md
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here